- Home>
- Specialties>
- Gastroenterology>
- Cirrhosis
Search for Cirrhosis in Gastroenterology
Physician-authored summaries on the latest research on cirrhosis, editorials on cirrhosis, and perspectives on cirrhosis - drawn from the top medical journals.
Sort by:
Items 1 to 20 of 165 results - Relevance
- Date
You searched for: cirrhosis in Gastroenterology
-
Are OTC Analgesics Safe for Patients with Cirrhosis?
- October 9, 2009
- Atif Zaman, MD, MPH
- Gastroenterology
Occasional low doses of acetaminophen seemed to be safe; the case for NSAIDs was less clear.- Reviewing:
- Khalid SK et al., Clin Gastroenterol Hepatol 2009 Sep; 7:994.
-
Identifying Cirrhosis in Patients with Hemochromatosis
- May 8, 2009
- Atif Zaman, MD, MPH
- Gastroenterology
When combinations of other markers failed, a specific concentration of hyaluronic acid paired with serum ferritin levels >1000 µg/L correctly identified cirrhosis in patients with hereditary hemochromatosis.- Reviewing:
- Crawford DHG et al., Hepatology 2009 Feb; 49:418.
-
Regression of Cirrhosis in HCV
- November 21, 2008
- Atif Zaman, MD, MPH
- Gastroenterology
Study findings suggest that HCV treatment can lead to regression of cirrhosis.
CME Exam- Reviewing:
- Mallet V et al., Ann Intern Med 2008 Sep 16; 149:399.
-
Long-Acting Octreotide Reduces Portal Pressure in Patients with Cirrhosis
- August 30, 2007
- Atif Zaman, MD, MPH
- Gastroenterology
In a small study, monthly intramuscular injections of octreotide resulted in significant reductions in portal hypertension.
CME Exam- Reviewing:
- Spahr L et al., Am J Gastroenterol 2007 Jul; 102:1397-405.
-
Interferon Therapy Improves Outcomes in HCV Patients with Cirrhosis
- June 1, 2007
- Atif Zaman, MD, MPH
- Gastroenterology
Clinical endpoints were evaluated in a group of cirrhotic patients with well-compensated disease.
CME Exam- Reviewing:
- Bruno S et al., Hepatology 2007 Mar; 45:579-87.
-
Adefovir and Entecavir Are Cost-Effective in Patients with HBV-Related Cirrhosis
- December 8, 2006
- Atif Zaman, MD, MPH
- Gastroenterology
Although adefovir and entecavir are more expensive than lamivudine, they are more cost-effective in this population.- Reviewing:
- Kanwal F et al., Am J Gastroenterol 2006 Sep; 101:2076-89.
-
Natural History of Hepatitis C–Related Cirrhosis
- October 6, 2006
- Atif Zaman, MD, MPH
- Gastroenterology
This long-term study of 214 untreated patients provides valuable data that will be useful in counseling patients.- Reviewing:
- Sangiovanni A et al., Hepatology 2006 Jun; 43:1303-10.
-
Hepatitis B Viral Load Predicts Cirrhosis Risk
- June 13, 2006
- Atif Zaman, MD, MPH
- Gastroenterology
Patients with higher viral loads are at higher risk for cirrhosis, independent of ALT level and HBeAg status.- Reviewing:
- Iloeje UH et al., Gastroenterology 2006 Mar; 130:678-86.
-
Combination Therapy vs. Monotherapy for Variceal Rebleeding
- September 19, 2008
- Atif Zaman, MD, MPH
- Gastroenterology
The combination of endoscopic and beta-blocker therapy is more effective in reducing rebleed rates than is either therapy alone, but it does not improve survival.
CME Exam- Reviewing:
- Gonzalez R et al., Ann Intern Med 2008 Jul 15; 149:109.
-
Irbesartan for Treatment of Portal Hypertension? Free
- August 22, 2008
- Atif Zaman, MD, MPH
- Gastroenterology
Adding this angiotensin II–receptor antagonist to propranolol does not further reduce hepatic venous pressure gradient.- Reviewing:
- Schepke M et al., Am J Gastroenterol 2008 May; 103:1152.
-
Can Platelet Count Indicate Risk for Varices?
- March 28, 2008
- Atif Zaman, MD, MPH
- Gastroenterology
Researchers studied the usefulness of changes in platelet count to predict gastroesophageal varices in patients with cirrhosis and portal hypertension.- Reviewing:
- Qamar AA et al., Hepatology 2008 Jan; 47:153.
-
Predicting Hepatic Decompensation in Cirrhotic Patients
- October 5, 2007
- Atif Zaman, MD, MPH
- Gastroenterology
Patients with hepatic venous pressure gradient measurements of <10 mm Hg were at low risk for developing decompensation within 4 years.
CME Exam- Reviewing:
- Ripoll C et al., Gastroenterology 2007 Aug; 133:481.
-
Variability of INR and Its Effect on MELD Scores
- September 21, 2007
- Atif Zaman, MD, MPH
- Gastroenterology
Whether standard INR measurements are reliable and reproducible in patients with liver disease has been questioned.- Reviewing:
- Tripodi A et al., Hepatology 2007 Aug; 46:520. Bellest L et al., Hepatology 2007 Aug; 46:528.
-
Using Liver Stiffness to Measure Portal Hypertension Noninvasively
- August 3, 2007
- Atif Zaman, MD, MPH
- Gastroenterology
Transient elastography could be a noninvasive way of identifying cirrhotic patients with clinically significant portal hypertension.- Reviewing:
- Vizzutti F et al., Hepatology 2007 May; 45:1290-7.
-
Maintenance Interferon Therapy for Patients with Chronic Hepatitis C Infections
- July 27, 2007
- Atif Zaman, MD, MPH
- Gastroenterology
Two years of maintenance monotherapy in high-risk HCV-positive cirrhotic patients is ineffective for lengthening complication-free survival.
CME Exam- Reviewing:
- Fartoux L et al., Clin Gastroenterol Hepatol 2007 Apr; 5:502-7.
-
Preventing Bacterial Infections in Cirrhotic Patients with Gastrointestinal Hemorrhage
- February 9, 2007
- Atif Zaman, MD, MPH
- Gastroenterology
Intravenous ceftriaxone is superior to oral norfloxacin in acute settings.
CME Exam- Reviewing:
- Fernández J et al., Gastroenterology 2006 Oct; 131:1049-56.
-
Balloon-Occluded Retrograde Transvenous Obliteration for Preventing Gastric Variceal Hemorrhage
- March 14, 2006
- Atif Zaman, MD, MPH
- Gastroenterology
This technique was effective for preventing primary bleeding in a small nonrandomized trial.- Reviewing:
- Takuma Y et al., Clin Gastroenterol Hepatol 2005 Dec; 3:1245-52.
-
Nonselective β-Blockers Don’t Prevent Varices in Cirrhotic Patients
- January 17, 2006
- Atif Zaman, MD, MPH
- Gastroenterology
β-blockers should be given only to cirrhotic patients with existing varices.- Reviewing:
- Groszmann RJ et al., N Engl J Med 2005 Nov 24; 353:2254-61.
-
Small Arterial Phase-Enhancing Hepatic Lesions Usually Are Benign
- August 30, 2005
- Atif Zaman, MD, MPH
- Gastroenterology
Current guidelines advise that patients with cirrhosis undergo screening for hepatocellular carcinoma. Quite frequently, small arterial phase-enhancing lesions are encountered during screening with computed tomography . . .- Reviewing:
- O’Malley ME et al., Am J Gastroenterol 2005 Jul; 100:1523-8.
-
MELD Score Predicts Mortality After Cholecystectomy in Cirrhotic Patients
- May 10, 2005
- Atif Zaman, MD, MPH
- Gastroenterology
Cirrhotic patients have an increased risk for cholelithiasis and postoperative complications after abdominal surgery. Currently, the Child-Pugh score is used to assess operative risk in . . .- Reviewing:
- Perkins L et al., Clin Gastroenterol Hepatol 2004 Dec; 2:1123-8.
Sort by:
Items 1 to 20 of 165 results - Relevance
- Date
